US Stock MarketDetailed Quotes
LIPO Lipella Pharmaceuticals
- 0.744
- -0.006-0.79%
Close May 3 16:00 ET
5.24MMarket Cap-966P/E (TTM)
0.796High0.741Low15.05KVolume0.796Open0.750Pre Close11.70KTurnover0.36%Turnover RatioLossP/E (Static)7.04MShares2.71052wk High1.66P/B3.16MFloat Cap0.64052wk Low--Dividend TTM4.25MShs Float7.720Historical High--Div YieldTTM7.33%Amplitude0.640Historical Low0.777Avg Price1Lot Size
About Lipella Pharmaceuticals Company
Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA.
Company Profile
SymbolLIPO
Company NameLipella Pharmaceuticals
Listing DateDec 20, 2022
Founded2005
CEODr. Jonathan Kaufman, M.B.A.,PhD
MarketNASDAQ
Employees7
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address7800 Susquehanna Street,Suite 505
CityPittsburgh
ProvincePennsylvania
CountryUnited States of America
Zip Code15208
Phone1-412-901-0315
Websitehttp://www.lipella.com
Company Executives
- Name
- Position
- Salary
- Dr. Jonathan Kaufman, M.B.A.,PhD
- Chairman of the Board, President, Chief Executive Officer, Secretary and Treasurer
- 323.38K
- Dr. Michael Chancellor, M.D.
- Chief Medical Officer and Director
- 315.08K
- Douglas Johnston, C.P.A.
- Chief Financial Officer
- 260.00K
- Ryan Pruchnic, M.B.A.
- Independent Director
- 62.50K
- Dr. Lori Birder, PhD
- Independent Director
- 12.50K
- Dr. Byong Kim, PhD
- Independent Director
- 63.30K
- Daniel R. Cohen, M.B.A.
- Independent Director
- 63.63K
- Dr. Naoki Yoshimura, M.D.,PhD
- Independent Director
- 62.50K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg